The authors evaluated the inhibitory activity of the chimeric protein against breast cancer cells in vitro and in vivo. They developed a novel multifunctional protein, consisting of p28, as a tumor-homing killer peptide fused to apoptin as a tumor-selective killer.
[Proteins-Structure Function and Bioinformatics]
Sorry, but the selected Zotpress account can't be found.
